Regenerative Medicine Market to Garner $83.19 Bn, Globally, by 2030 at 23.4% CAGR: Allied Market Research

Increase in adoption of stem cell technology, emergence of application of nanotechnology, and rise in prevalence of chronic diseases and trauma emergencies drive the growth of the global regenerative medicine market.

PORTLAND, Ore., March 14, 2022 /PRNewswire/ -- Allied Market Research recently published a report, titled, "Regenerative Medicine Market by Product Type (Cell Therapy, Gene Therapy, Tissue Engineering, and Small Molecule & Biologic), Material (Synthetic Material, Biologically Derived Material, Genetically Engineered Material, and Pharmaceuticals), Application (Cardiovascular, Oncology, Dermatology, Musculoskeletal, Wound Healing, Ophthalmology, Neurology, and Others) and End user (Hospitals, Ambulatory Surgical Centers, and Others: Global Opportunity Analysis and Industry Forecast, 2021–2030." As per the report, the global regenerative medicine industry was accounted for $10.10 billion in 2020, and is expected to reach $83.19 billion by 2030, growing at a CAGR of 23.4% from 2021 to 2030.

For Right Perspective, Download Sample PDF at: https://www.alliedmarketresearch.com/request-sample/391

Drivers, restraints, and opportunities-

Increase in adoption of stem cell technology, emergence of application of nanotechnology, and rise in prevalence of chronic diseases and trauma emergencies drive the growth of the global regenerative medicine market. On the other hand, certain ethical hurdles and costly treatment associated with regenerative medicines impede the growth to some extent. However, increase in potential in the emerging economies is expected to create lucrative opportunities in the industry.

Covid-19 scenario-

• The outbreak of the pandemic has had a positive impact on the global regenerative medicine market. For instance, in 2020, Singapore based Duke-NUS medical school's emerging infectious disease program demonstrated the utility of immunotherapies in the treatment of COVID-19. 
• This drift is most likely to continue post pandemic as well.

The cell therapy segment held the lion's share-

Based on product type, the cell therapy segment held the major share in 2020, generating more than three-fifths of the global regenerative medicine market. This is due to increase in prevalence of cardiovascular surgeries across the world. The gene therapy segment, on the other hand, is projected to cite the fastest CAGR of 24.7% during the forecast period.

Do You Have Any Query Or Specific Requirement? Ask to Our Industry Expert: https://www.alliedmarketresearch.com/purchase-enquiry/391

The synthetic materials segment held the highest share in 2020-

Based on material, the synthetic materials segment held the highest share in 2020, generating nearly one-third of the global regenerative medicine market. This is owing to rise in prevalence of dental disorders among individuals. The pharmaceuticals segment, however, would cite the fastest CAGR of 23.8% from 2021 to 2030.

North America held the major share-

Based on region, the market across North America accounted for the major share in 2020, contributing to nearly half of the global regenerative medicine market. Robust infrastructure provided for research activities and the huge presence of key players across North America boost the market growth. Asia-Pacific, simultaneously, is expected to cite the fastest CAGR of 25.5% throughout the forecast period. Increase in use of regenerative medicine products, surge in R & D activities for new product launch, and rise in investments in the healthcare sector propel the growth of the market.

Prominent market players-

• Zimmer Biomet Holdings, Inc.
• Medtronic Plc.
• U.S. Stem Cell, Inc. (Bioheart, Inc.)
• Acelity Holdings, Inc.
• Organogenesis, Inc. (Advanced Biohealing)
• Stryker Corporation
• Integra Lifesciences Holdings Corporation
• Isto Biologics (Isto Biologics Medical Systems, Inc.)
• CryoLife, Inc.
• Athersys, Inc.

Avenue Basic Plan | Library Access | 1 Year Subscription |

Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.

Request for 14 days free trial: https://www.alliedmarketresearch.com/avenue/trial/starter

"We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market."

Trending Reports in Healthcare Industry (Book Now with 10% Discount):

• mHealth Market - Global Opportunity Analysis and Industry Forecast, 2020–2028
• Nurse Call Systems Market - Global Opportunity Analysis and Industry Forecast, 2020-2028
• Prefilled Syringes Market - Global Opportunity Analysis and Industry Forecast, 2020-2028
• Pharmaceutical Packaging Market - Global Opportunity Analysis and Industry Forecast, 2020–2028
• Workplace Stress Management Market - Global Opportunity Analysis and Industry Forecast, 2020–2028

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com/reports-store/life-sciences
Follow Us on LinkedIn: https://www.linkedin.com/showcase/life-sciences-industry-research/

Logo: https://mma.prnewswire.com/media/636519/Allied_Market_Research_Logo.jpg